Beth Cywin

Affiliations
  • Astellas Pharma Global Development, Inc., 60062, Northbrook, United States.

Publications (2)

A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients.

EClinicalMedicine
Avec: Per Ljungman , Arancha Bermudez , Aaron C Logan , Mohamed A Kharfan-Dabaja , Patrice Chevallier , Rodrigo Martino , Gerald Wulf , Dominik Selleslag , Kazuhiko Kakihana , Amelia Langston , Dong-Gun Lee , Carlos Solano , Shinichiro Okamoto , Larry R Smith , Michael Boeckh , John R Wingard , Beth Cywin , Christine Fredericks , Christopher Lademacher , Xuegong Wang , James Young , Johan Maertens

Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years.

Vaccine
Avec: Gurunadh R Chichili , Ronald Smulders , Vicki Santos , Beth Cywin , Laura Kovanda , Charles Van Sant , Frank Malinoski , Shite Sebastian , George Siber , Richard Malley

Réseau de co-auteurs

Per Ljungman 1 collaboration
Arancha Bermudez 1 collaboration
Aaron C Logan 1 collaboration
Mohamed A Kharfan-Dabaja 1 collaboration
Patrice Chevallier 1 collaboration
Rodrigo Martino 1 collaboration
Gerald Wulf 1 collaboration
Dominik Selleslag 1 collaboration
Kazuhiko Kakihana 1 collaboration
Amelia Langston 1 collaboration
Dong-Gun Lee 1 collaboration
Carlos Solano 1 collaboration
Shinichiro Okamoto 1 collaboration
Larry R Smith 1 collaboration
Michael Boeckh 1 collaboration
John R Wingard 1 collaboration
Christine Fredericks 1 collaboration
Christopher Lademacher 1 collaboration
Xuegong Wang 1 collaboration
James Young 1 collaboration
Johan Maertens 1 collaboration
Gurunadh R Chichili 1 collaboration
Ronald Smulders 1 collaboration
Vicki Santos 1 collaboration
Laura Kovanda 1 collaboration
Charles Van Sant 1 collaboration
Frank Malinoski 1 collaboration
Shite Sebastian 1 collaboration
George Siber 1 collaboration
Richard Malley 1 collaboration